PMC5808257_01
HE 20X.
cm-91-112f1.jpg
PMC5808257_01_cm-91-112f1.jpg
f1-cm-91-112
HE 10X.
cm-91-112f2.jpg
PMC5808257_01_cm-91-112f2.jpg
f2-cm-91-112
HE 40X.
cm-91-112f3.jpg
PMC5808257_01_cm-91-112f3.jpg
f3-cm-91-112
HE 40X.
cm-91-112f4.jpg
PMC5808257_01_cm-91-112f4.jpg
f4-cm-91-112
S100+, 10X.
cm-91-112f5.jpg
PMC5808257_01_cm-91-112f5.jpg
f5-cm-91-112
The immunohistochemical analysis revealed the existance of malignant melanoma metastasis at the level of the lymph node S100 + (Figure 5), MART1 + (Figure 6) corresponding to the immune profile of the biopsy piece taken from the hallux the S100 + (Figure 7) MART1 + (Figure 8).
MART1+, 10X.
cm-91-112f6.jpg
PMC5808257_01_cm-91-112f6.jpg
f6-cm-91-112
The immunohistochemical analysis revealed the existance of malignant melanoma metastasis at the level of the lymph node S100 + (Figure 5), MART1 + (Figure 6) corresponding to the immune profile of the biopsy piece taken from the hallux the S100 + (Figure 7) MART1 + (Figure 8).
S100+, 10X.
cm-91-112f7.jpg
PMC5808257_01_cm-91-112f7.jpg
f7-cm-91-112
The immunohistochemical analysis revealed the existance of malignant melanoma metastasis at the level of the lymph node S100 + (Figure 5), MART1 + (Figure 6) corresponding to the immune profile of the biopsy piece taken from the hallux the S100 + (Figure 7) MART1 + (Figure 8).
MART1+, 10X.
cm-91-112f8.jpg
PMC5808257_01_cm-91-112f8.jpg
f8-cm-91-112
The immunohistochemical analysis revealed the existance of malignant melanoma metastasis at the level of the lymph node S100 + (Figure 5), MART1 + (Figure 6) corresponding to the immune profile of the biopsy piece taken from the hallux the S100 + (Figure 7) MART1 + (Figure 8).
BRAF neg., 10X.
cm-91-112f9.jpg
PMC5808257_01_cm-91-112f9.jpg
f9-cm-91-112
The presence of the BRAF gene was also evaluated and considered negative. (Figure 9).